Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.

Owen, R G

Owen, R G.

Affiliation

Owen RG; Department of Haematology, The General Infirmary at Leeds, UK. rgo@ukgateway.net

Expert Opin Pharmacother ; 2(6): 945-52, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11585010

Subject(s)

Antimetabolites/therapeutic use; Purine Nucleosides/therapeutic use; Waldenstrom Macroglobulinemia/drug therapy; Alkylating Agents/therapeutic use; Chlorambucil/therapeutic use; Cladribine/therapeutic use; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Guidelines as Topic; Humans; Middle Aged; Pentostatin/therapeutic use; Plasmapheresis; Quality of Life; Vidarabine/analogs & derivatives; Vidarabine/therapeutic use; Waldenstrom Macroglobulinemia/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Purine Nucleosides / Waldenstrom Macroglobulinemia / Antimetabolites Type of study: Guideline Aspects: Patient_preference Limits: Humans / Middle aged Language: En Journal: Expert Opin Pharmacother Year: 2001 Document type: Article

Search on Google

XML

PubMed Links